首页> 外国专利> laquinimod combination therapy for treatment of multiple sclerosis

laquinimod combination therapy for treatment of multiple sclerosis

机译:拉喹莫德联合疗法治疗多发性硬化症

摘要

1/1 Summary "Laquinimod Combination Therapy for the Treatment of Multiple Sclerosis" The present invention provides a method for treating a subject afflicted with a form of multiple sclerosis (ms) or presenting a clinically isolated syndrome (cis) comprising periodically administering to the subject to an amount of laquinimod and an amount of a compound of formula (i): as described herein. The present invention also provides pharmaceutical packages and compositions comprising laquinimod and a compound of formula (I) as described herein. The present invention further provides uses of said compounds, pharmaceutical compositions and packages for treating a subject afflicted with a ms form or having a cis.
机译:1/1概述“用于治疗多发性硬化症的拉喹莫德联合疗法”本发明提供了一种用于治疗患有多发性硬化症(ms)形式或表现出临床分离的综合症(cis)的受试者的方法,其包括定期给予该受试者量的拉喹莫德和一定量的式(i)化合物:如本文所述。本发明还提供了包含拉喹莫德和本文所述的式(I)化合物的药物包装和组合物。本发明进一步提供了所述化合物,药物组合物和包装在治疗患有ms形式或具有顺式的受试者中的用途。

著录项

  • 公开/公告号BR112016006582A2

    专利类型

  • 公开/公告日2017-08-01

    原文格式PDF

  • 申请/专利权人 TEVA PHARMACEUTICAL INDUSTRIES LTD.;

    申请/专利号BR20161106582

  • 发明设计人 JOEL KAYE;VOLKER KNAPPERTZ;

    申请日2014-09-26

  • 分类号A61K31/225;

  • 国家 BR

  • 入库时间 2022-08-21 13:39:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号